Quantitative plasma proteome profiling of COVID-19 patients with mild and moderate symptoms

被引：0
|
作者：
Jiang, He-Wei [1 ]
Tao, Sheng-Ce [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Shanghai Ctr Syst Biomed, Minist Educ, Key Lab Syst Biomed, Shanghai, Peoples R China
来源：
EBIOMEDICINE | 2022年 / 75卷
关键词：
D O I：
10.1016/j.ebiom.2021.103773
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Proteomic blood profiling in mild, severe and critical COVID-19 patients
    Hamel Patel
    Nicholas J. Ashton
    Richard J. B. Dobson
    Lars-Magnus Andersson
    Aylin Yilmaz
    Kaj Blennow
    Magnus Gisslen
    Henrik Zetterberg
    Scientific Reports, 11
  • [32] Patients With Mild COVID-19 at Risk of Some Post-COVID-19 Condition Symptoms
    Larkin, Howard D.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 329 (05): : 364 - 364
  • [33] Influence of isolation measures for patients with mild symptoms on the spread of COVID-19
    Pan, Qiuhui
    Gao, Ting
    He, Mingfeng
    CHAOS SOLITONS & FRACTALS, 2020, 139
  • [34] The Effect of Ivermectin on Reducing Viral Symptoms in Patients with Mild COVID-19
    Abbas, K. U.
    Muhammad, S.
    Ding, S. F.
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2022, 84 : 87 - 91
  • [35] Dynamics of Viral Shedding and Symptoms in Patients with Asymptomatic or Mild COVID-19
    Bae, Seongman
    Kim, Ji Yeun
    Lim, So Yun
    Park, Heedo
    Cha, Hye Hee
    Kwon, Ji-Soo
    Suh, Mi Hyun
    Lee, Hyun Jung
    Lim, Joon Seo
    Jung, Jiwon
    Kim, Min Jae
    Chong, Yong Pil
    Lee, Sang-Oh
    Choi, Sang-Ho
    Kim, Yang Soo
    Lee, Ho Young
    Lee, Sohyun
    Park, Man-Seong
    Kim, Sung-Han
    VIRUSES-BASEL, 2021, 13 (11):
  • [36] Evaluation of antibody titers in COVID-19 patients with cerebral or pulmonary symptoms and mild symptoms
    Joudaki, Nazanin
    Ghafouri, Samireh
    Bavarsad, Kowsar
    Farhadi, Farbod
    Nasab, Marzieh Abbasi
    Afzalzadeh, Sara
    Moradzadegan, Hamidreza
    Kahyesh, Roya Salehi
    IRANIAN JOURNAL OF MICROBIOLOGY, 2024, 16 (01) : 124 - 131
  • [37] Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19
    Dougan, M.
    Nirula, A.
    Azizad, M.
    Mocherla, B.
    Gottlieb, R. L.
    Chen, P.
    Hebert, C.
    Perry, R.
    Boscia, J.
    Heller, B.
    Morris, J.
    Crystal, C.
    Igbinadolor, A.
    Huhn, G.
    Cardona, J.
    Shawa, I
    Kumar, P.
    Adams, A. C.
    Van Naarden, J.
    Custer, K. L.
    Durante, M.
    Oakley, G.
    Schade, A. E.
    Holzer, T. R.
    Ebert, P. J.
    Higgs, R. E.
    Kallewaard, N. L.
    Sabo, J.
    Patel, D. R.
    Dabora, M. C.
    Klekotka, P.
    Shen, L.
    Skovronsky, D. M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (15): : 1382 - 1392
  • [38] Kidney outcome after mild to moderate COVID-19
    Schmidt-Lauber, Christian
    Haenzelmann, Sonja
    Schunk, Stefan
    Petersen, Elina L.
    Alabdo, Ammar
    Lindenmeyer, Maja
    Hausmann, Fabian
    Kuta, Piotr
    Renne, Thomas
    Twerenbold, Raphael
    Zeller, Tanja
    Blankenberg, Stefan
    Fliser, Danilo
    Huber, Tobias B.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 (09) : 2031 - 2040
  • [39] Neutralizing Monoclonal Antibody for Mild to Moderate COVID-19
    Malani, Preeti N.
    Golub, Robert M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (07): : 644 - 645
  • [40] New Antiviral on the Horizon for Mild to Moderate COVID-19
    Harris, Emily
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 331 (10): : 821
12345